Clinical Profile, Pharmacological Treatment, and Predictors of Death Among Hospitalized COVID-19 Patients With Acute Kidney Injury: A Population-Based Registry Analysis

Frontiers in Medicine

Eduardo Tamayo¹  Débora Martín-García²  F. Javier Álvarez³  Francisco Herrera-Gómez⁴  Eduardo Gutiérrez-Abejón⁵ 

[1]BioCritic. Group for Biomedical Research in Critical Care Medicine, Valladolid, Spain

[2]Department of Anaesthesiology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain

[3]Department of Surgery, Faculty of Medicine, University of Valladolid, Valladolid, Spain

[4]Department of Nephrology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain

[5]Pharmacological Big Data Laboratory, Faculty of Medicine, University of Valladolid, Valladolid, Spain

[6]BioCritic. Group for Biomedical Research in Critical Care Medicine, Valladolid, Spain

[7]Comité de Ética de la Investigación con medicamentos, Hospital Clínico Universitario de Valladolid, Valladolid, Spain

[8]Pharmacological Big Data Laboratory, Faculty of Medicine, University of Valladolid, Valladolid, Spain

[9]BioCritic. Group for Biomedical Research in Critical Care Medicine, Valladolid, Spain

[10]Unit of Kidney Resuscitation and Acute Purification Therapies, Hospital Virgen de la Concha, Zamora, Spain

[11]Transplantation Center, Lausanne University Hospital & University of Lausanne, Lausanne, Switzerland

[12]Pharmacological Big Data Laboratory, Faculty of Medicine, University of Valladolid, Valladolid, Spain

[13]Technical Direction of Pharmaceutical Assistance, Gerencia Regional de Salud de Castilla y León, Valladolid, Spain

关键词: SARS-CoV-2;    COVID-19;    acute kidney injury;    chronic kidney disease;    treatment;    mortality;   

DOI  :  10.3389/fmed.2021.657977

来源: Frontiers

【 授权许可】

CC BY